JPH0529348B2 - - Google Patents

Info

Publication number
JPH0529348B2
JPH0529348B2 JP61280557A JP28055786A JPH0529348B2 JP H0529348 B2 JPH0529348 B2 JP H0529348B2 JP 61280557 A JP61280557 A JP 61280557A JP 28055786 A JP28055786 A JP 28055786A JP H0529348 B2 JPH0529348 B2 JP H0529348B2
Authority
JP
Japan
Prior art keywords
methyl
hydrogen
compound according
carbon atoms
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61280557A
Other languages
English (en)
Japanese (ja)
Other versions
JPS62149652A (ja
Inventor
Patoritsuku Ritsuji Jeemuzu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Original Assignee
Pfizer Corp Belgium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium filed Critical Pfizer Corp Belgium
Publication of JPS62149652A publication Critical patent/JPS62149652A/ja
Publication of JPH0529348B2 publication Critical patent/JPH0529348B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP61280557A 1985-11-25 1986-11-25 免疫刺激ペプチド Granted JPS62149652A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8502351 1985-11-25
WO85/02351 1985-11-25
US900934 1986-08-27

Publications (2)

Publication Number Publication Date
JPS62149652A JPS62149652A (ja) 1987-07-03
JPH0529348B2 true JPH0529348B2 (enExample) 1993-04-30

Family

ID=22188957

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61280557A Granted JPS62149652A (ja) 1985-11-25 1986-11-25 免疫刺激ペプチド

Country Status (9)

Country Link
EP (1) EP0227306B1 (enExample)
JP (1) JPS62149652A (enExample)
AT (1) ATE46347T1 (enExample)
DD (2) DD280764A5 (enExample)
DE (1) DE3665593D1 (enExample)
GR (1) GR3000215T3 (enExample)
IE (1) IE59116B1 (enExample)
SU (1) SU1507212A3 (enExample)
ZA (1) ZA868873B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI890886A0 (fi) * 1986-08-27 1989-02-24 Pfizer Kristallin n-(s-3-metylheptanoyl) -d-gamma-glutamyl-glycyl-d-alanin och foerfaranden foer dess framstaellning samt mellanprodukter.
WO1988001612A1 (en) * 1986-08-27 1988-03-10 Pfizer Inc. Processes and intermediates for n-(s-3-alkyl-heptanoyl)-d-gamma-glutamyl-glycyl-d-alanine
JPH0621170U (ja) * 1992-04-21 1994-03-18 多治見無線電機株式会社 電気コネクタ
DE19712633A1 (de) * 1997-03-26 1998-10-08 Laves Arzneimittel Verwendung von gamma-Aminobuttersäure als Interleukinbildungsstimulans

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK156252C (da) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf

Also Published As

Publication number Publication date
DD280764A5 (de) 1990-07-18
SU1507212A3 (ru) 1989-09-07
IE863088L (en) 1987-05-25
ZA868873B (en) 1988-07-27
DD286363A5 (de) 1991-01-24
DE3665593D1 (en) 1989-10-19
GR3000215T3 (en) 1990-12-31
ATE46347T1 (de) 1989-09-15
EP0227306A3 (en) 1988-09-07
IE59116B1 (en) 1994-01-12
JPS62149652A (ja) 1987-07-03
EP0227306B1 (en) 1989-09-13
EP0227306A2 (en) 1987-07-01

Similar Documents

Publication Publication Date Title
KR870000372B1 (ko) 아실트리펩타이드의 제조방법
RU2135515C1 (ru) Карбаматы и карбамиды, индуцирующие производство цитокинов
FI78684C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara cis, endo-2-azabicyklo-/5.3.0/-dekan-3- karboxylsyraderivat och mellanprodukter.
CA1318457C (en) Partially retro-inverted tuftsin analogues, method for the preparation thereof and pharmaceutical compositions containing them
GB2086393A (en) Bicyclic compounds
EP1003727A1 (en) Antibiotic for methicillin resistant bacteria
DK154436B (da) Analogifremgangsmaade til fremstilling af tri-, tetra- og pentapeptider eller salte deraf
JPS60136595A (ja) 置換エチレンジアミン誘導体、その製造方法及び該誘導体を含む医薬製剤
KR870000810B1 (ko) 펩타이드-치환된 헤테로사이클릭 화합물의 제조방법
JPH0529348B2 (enExample)
US4767743A (en) Peptide immunostimulants
HU201094B (en) Process for producing immunostimulant acyltripeptides and pharmaceutical compositions comprising same as active ingredient
AP1057A (en) Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides.
KR900004648B1 (ko) 펩타이드 유도체의 제조방법
WO2002036551A1 (en) Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof
HU188110B (en) Process for producing new tripeptide-derivatives
IE60041B1 (en) Crystalline n-(s-3-methylheptanoyl)-d-gamma-glutamyl-glycyl-d-alanine, and processes and intermediates therefor
HU185978B (en) Process for preparing new tetrapeptide derivatives
HU205062B (en) Process for producing n-(s-3-methylheptanoyl or -heptenoyl)-d-gamma-glutamyl-glycine-d-alanine
CN85102340A (zh) 制备免疫刺激剂酰三肽的方法